A Review of Epidemiological Approaches to Forecasting Mortality and Morbidity

This chapter discusses epidemiological models that take disease processes and related risk factors as the basis for modelling mortality and morbidity. These models can be roughly divided into two groups: statistical regression models and dynamic multistate models. For each group of models, examples are given for infectious and chronic diseases. Strong and weak aspects of each group of models are summarised in the context of their aims and data requirements. The chapter consists of four sections. Section 2.1 is an introduction. In Section 2.2, devoted to the regression models, the Alderson and Ashwood model for prediction of lung cancer mortality in England and Wales and the Murray and Lopez study of the global burden of disease are discussed. Section 2.3 focuses on dynamic multistate models. In Section 2.3.1 the (macrosimulation) method of back-calculation of HIV/AIDS-related mortality, and a (microsimulation) model of the spread of two sexually transmitted diseases, gonorrhoea and chlamydia, are given as examples of the multistate models for infectious diseases. The Dutch model PREVENT and the risk factor intervention models of Manton and colleagues are reported in Section 2.3.2 as examples of the multistate models of chronic diseases. Finally, the models MISCAN (Erasmus University, Rotterdam) and POHEM (Statistics Canada) illustrate the microsimulation approach in multistate modelling of chronic diseases. The final section (2.4) discusses the use of epidemiological models for research and health policy purposes.

[1]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[2]  M. Wolfson,et al.  POHEM--a framework for understanding and modelling the health of human populations. , 1994, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[3]  K G Manton,et al.  Projecting the future size and health status of the U.S. elderly population. , 1992, International journal of forecasting.

[4]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[5]  Anne Lohrli Chapman and Hall , 1985 .

[6]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[7]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[8]  Smoking and lung cancer: a cohort data study of men and women in England and Wales 1935-70. , 1978 .

[9]  Alan D. Lopez,et al.  Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study , 1997, The Lancet.

[10]  G. V. Oortmarssen Evaluation of mass screening for cancer : a model-based approach , 1995 .

[11]  Hoogenveen Rt,et al.  The chronic diseases modelling approach , 1998 .

[12]  R. Doll,et al.  Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.

[13]  Kenneth G. Manton,et al.  The Oldest old , 1993 .

[14]  Kenneth G. Manton,et al.  Limits to human life expectancy: evidence prospects and implications. , 1991 .

[15]  M Susser,et al.  Choosing a future for epidemiology: I. Eras and paradigms. , 1996, American journal of public health.

[16]  Mnv,et al.  The Future of the Global Environment: A Model-based Analysis Supporting UNEP's First Global Environment Outlook , 1997 .

[17]  M. Alderson,et al.  Projection of mortality rates for the elderly , 1985 .

[18]  M E King,et al.  Use of modeling in infectious disease epidemiology. , 1988, American journal of epidemiology.

[19]  A M Downs,et al.  Reconstruction and prediction of the HIV/AIDS epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe , 1997, AIDS.

[20]  E. Gilpin,et al.  How long will today's new adolescent smoker be addicted to cigarettes? , 1996, American journal of public health.

[21]  N. Pearce,et al.  [Traditional epidemiology, modern epidemiology and public health]. , 1996, Epidemiologia e prevenzione.

[22]  J. Mackenbach Mortality and medical care : studies of mortality by cause of death in The Netherlands and other European countries , 1988 .

[23]  G. A. de Jong,et al.  Predicting the effects of mass-screening for disease — a simulation approach , 1981 .

[24]  L. Gunning-Schepers,et al.  The health benefits of prevention: a simulation approach. , 1988, Health policy.

[25]  M. Wolfson A SYSTEM OF HEALTH STATISTICS TOWARD A NEW CONCEPTUAL FRAMEWORK FOR INTEGRATING HEALTH DATA , 1991 .

[26]  R. Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[27]  Wolfgang Lutz,et al.  Future Demographic Trends in Europe and North America: What Can We Assume Today? , 1992 .

[28]  I M Longini,et al.  Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort. , 1993, American journal of epidemiology.

[29]  D. Cox Regression Models and Life-Tables , 1972 .

[30]  T. Mckeown The Role of Medicine , 1979 .

[31]  M. Kretzschmar,et al.  Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. , 1996, American journal of epidemiology.

[32]  A Wolman,et al.  The environment and disease. , 1976, Bulletin of the Pan American Health Organization.

[33]  B. Singer,et al.  Forecasting the health of elderly populations , 1993 .